NCT03398551

Brief Summary

The aim of this study is to get a proof of concept for using a computational model of fetal haemodynamics, combined with machine learning based on Doppler patterns of the fetal cardiovascular, cerebral and placental flows, to identify those at increased risk of adverse perinatal outcomes such as stillbirth, perinatal mortality and other neonatal morbidities. We will also compare the sensitivity and specificity of UmbiFlow device with the machine learning model in predicting adverse perinatal outcomes

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
525

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2018

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 6, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 12, 2018

Completed
20 days until next milestone

Study Start

First participant enrolled

February 1, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

January 12, 2018

Status Verified

January 1, 2018

Enrollment Period

7 months

First QC Date

January 6, 2018

Last Update Submit

January 6, 2018

Conditions

Keywords

pregnancymachine learningfetal Doppler echocardiography

Outcome Measures

Primary Outcomes (2)

  • Stillbirth

    Baby born with no signs of life at or after 28 weeks of gestation

    At birth

  • Early neonatal mortality

    Death of a baby within the first 7 days of life

    Within the first 7 days of life

Secondary Outcomes (5)

  • IUGR

    At birth

  • Prematurity

    At birth

  • Birth asphyxia

    At birth

  • Neonatal sepsis

    Within the first 7 days of life

  • Low Birth Weight

    At birth

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study will recruit pregnant women only.
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women between 22-34 weeks who reside in Ibrahim Hyderi Goth which is a peri-urban settlement of approximately 70,000 on the south east of Karachi. It is one of the seven union councils in Bin Qasim town which has a population of one million.

You may qualify if:

  • Pregnant woman coming to the ultrasound clinic between 22-34 weeks of gestation.
  • Written informed consent
  • Resident of the study area

You may not qualify if:

  • Multiple gestation
  • Known congenital anomaly in the fetus or newborn
  • Refusal for the ultrasound
  • Poor echocardiographic images for Doppler acquisition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Perinatal Death

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Zahra Hoodbhoy

Study Record Dates

First Submitted

January 6, 2018

First Posted

January 12, 2018

Study Start

February 1, 2018

Primary Completion

September 1, 2018

Study Completion

December 1, 2018

Last Updated

January 12, 2018

Record last verified: 2018-01